International Association for the Study of Lung Cancer (IASLC) shared on LinkedIn:
“2 decades of progress have transformed the role of immunotherapy in lung cancer.
In the newest episode of JTO Insights, Dr. Alex Adjei and Dr. Tom John welcome Dr. Karen Reckamp, author of the September Journal of Thoracic Oncology article, The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective.
Tune in for a look at the evolution of immunotherapy and its impact on lung cancer care over the past 20 years.
You can also read ‘10 Ongoing Clinical Trials on Immunotherapy in Lung Cancer‘
